Inhibition_NN
of_IN
T_NN
lymphocyte_NN
activation_NN
by_IN
cAMP_NN
is_VBZ
associated_VBN
with_IN
down-regulation_NN
of_IN
two_CD
parallel_JJ
mitogen-activated_JJ
protein_NN
kinase_NN
pathways_NNS
,_,
the_DT
extracellular_JJ
signal-related_JJ
kinase_NN
and_CC
c-Jun_NN
N-terminal_JJ
kinase_NN
._.

The_DT
induction_NN
of_IN
T_NN
cell_NN
proliferation_NN
requires_VBZ
signals_NNS
from_IN
the_DT
TCR_NN
and_CC
a_DT
co-receptor_NN
molecule_NN
,_,
such_JJ
as_IN
CD28_NN
,_,
that_WDT
activate_VBP
parallel_JJ
and_CC
partially_RB
cross-reactive_JJ
signaling_NN
pathways_NNS
._.

These_DT
pathways_NNS
are_VBP
disrupted_VBN
by_IN
agonists_NNS
that_WDT
utilize_VBP
adenylate_JJ
cyclase_NN
and_CC
cAMP-dependent_JJ
protein_NN
kinase_NN
A_NN
-LRB-_-LRB-
PKA_NN
-RRB-_-RRB-
._.

We_PRP
found_VBD
that_IN
the_DT
adenylate_JJ
cyclase_NN
activator_NN
,_,
forskolin_NN
,_,
inhibits_VBZ
anti-CD3-induced_JJ
shift_NN
in_IN
Lck_NN
electrophoretic_JJ
mobility_NN
,_,
suggesting_VBG
an_DT
intervention_NN
at_IN
the_DT
TCR-coupled_JJ
phosphoinositide_NN
turnover_NN
that_WDT
precedes_VBZ
the_DT
activation_NN
of_IN
PKC_NN
._.

The_DT
shift_NN
of_IN
Lck_NN
following_VBG
direct_JJ
PKC_NN
activation_NN
by_IN
12-O-tetradecanoyl_NN
phorbol_NN
13-acetate_NN
,_,
which_WDT
bypasses_VBZ
early_JJ
receptor-triggered_JJ
biochemical_JJ
events_NNS
,_,
is_VBZ
insensitive_JJ
to_TO
forskolin_NN
._.

Nevertheless_RB
,_,
forskolin_NN
also_RB
inhibits_VBZ
PKC_NN
downstream_JJ
events_NNS
,_,
such_JJ
as_IN
c-jun_NN
expression_NN
,_,
which_WDT
is_VBZ
critical_JJ
for_IN
the_DT
activation_NN
process_NN
of_IN
T_NN
cells_NNS
._.

To_TO
further_RB
analyze_VB
potential_JJ
cross_JJ
points_NNS
between_IN
positively_RB
and_CC
negatively_RB
regulating_VBG
signaling_NN
pathways_NNS
in_IN
T_NN
cells_NNS
,_,
we_PRP
tested_VBD
the_DT
effects_NNS
of_IN
activators_NNS
of_IN
the_DT
adenylate_JJ
cyclase_NN
or_CC
PKA_NN
on_IN
two_CD
parallel_JJ
mitogen-activated_JJ
protein_NN
kinase_NN
signaling_NN
pathways_NNS
mediated_VBN
by_IN
extracellular_JJ
signal-regulated_JJ
kinase_NN
-LRB-_-LRB-
ERK_NN
-RRB-_-RRB-
and_CC
c-Jun_NN
N-terminal_JJ
kinase_NN
._.

Using_VBG
a_DT
PKC-specific_JJ
inhibitor_NN
,_,
GF109203X_NN
,_,
or_CC
PKC-depleted_JJ
T_NN
cells_NNS
,_,
we_PRP
found_VBD
that_IN
a_DT
large_JJ
part_NN
of_IN
the_DT
anti-CD3-induced_JJ
ERK_NN
activation_NN
is_VBZ
PKC_NN
dependent_JJ
._.

Both_CC
PKC-dependent_JJ
and_CC
-_NN
independent_JJ
activation_NN
of_IN
ERK_NN
were_VBD
sensitive_JJ
to_TO
inhibition_NN
by_IN
forskolin_NN
or_CC
a_DT
cell-permeable_JJ
cAMP_NN
analog_NN
,_,
dbcAMP_NN
._.

Furthermore_RB
,_,
the_DT
effect_NN
of_IN
12-O-tetradecanoyl_NN
phorbol_NN
13-acetate_NN
and_CC
ionomycin_NN
,_,
which_WDT
synergized_VBD
to_TO
fully_RB
activate_VB
c-Jun_NN
N-terminal_JJ
kinase_NN
,_,
was_VBD
also_RB
sensitive_JJ
to_TO
inhibition_NN
by_IN
forskolin_NN
._.

Our_PRP$
results_NNS
suggest_VBP
that_IN
PKA_NN
inhibits_VBZ
T_NN
cell_NN
activation_NN
by_IN
interfering_VBG
with_IN
multiple_JJ
events_NNS
along_IN
the_DT
two_CD
signaling_NN
pathways_NNS
operating_VBG
downstream_JJ
of_IN
the_DT
TCR_NN
and_CC
the_DT
CD28_NN
co-receptor_NN
molecules_NNS
._.

